For instance, a study showed that the cumulative incidence of local breast cancer recurrence in BRCA1/2 mutation carriers was 32% within 15 years after a breast‐conserving surgery (e.g., lumpectomy) and 9% after total mastectomy.3 This evidence concerns the gene BRCA1 and breast carcinoma.